Skip to main content
PMC home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 2002 May;71(1):68–71.

Anti Jo-1 myositis. 'Mechanic's hands' and interstitial lung disease.

A J Taggart 1, M B Finch 1, P A Courtney 1, G J Gormley 1
PMCID: PMC2475351  PMID: 12137171

Full text

PDF

Images in this article

69Fig 1
on p.69
69Fig 2
on p.69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bohan A., Peter J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975 Feb 13;292(7):344–347. doi: 10.1056/NEJM197502132920706. [DOI] [PubMed] [Google Scholar]
  2. Dickey B. F., Myers A. R. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum. 1984 Aug;14(1):60–76. doi: 10.1016/0049-0172(84)90010-6. [DOI] [PubMed] [Google Scholar]
  3. Gabriel S. E., Bombardier C. NSAID induced ulcers. An emerging epidemic? J Rheumatol. 1990 Jan;17(1):1–4. [PubMed] [Google Scholar]
  4. Haupt H. M., Hutchins G. M. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol. 1982 Nov;50(5):998–1006. doi: 10.1016/0002-9149(82)90408-8. [DOI] [PubMed] [Google Scholar]
  5. Joffe M. M., Love L. A., Leff R. L., Fraser D. D., Targoff I. N., Hicks J. E., Plotz P. H., Miller F. W. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med. 1993 Apr;94(4):379–387. doi: 10.1016/0002-9343(93)90148-i. [DOI] [PubMed] [Google Scholar]
  6. Lee W., Zimmermann B., 3rd, Lally E. V. Relapse of polymyositis after prolonged remission. J Rheumatol. 1997 Aug;24(8):1641–1644. [PubMed] [Google Scholar]
  7. Love L. A., Leff R. L., Fraser D. D., Targoff I. N., Dalakas M., Plotz P. H., Miller F. W. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991 Nov;70(6):360–374. doi: 10.1097/00005792-199111000-00002. [DOI] [PubMed] [Google Scholar]
  8. Martin L., Chalmers I. M., Dhingra S., McCarthy D., Hunter T. Measurements of maximum respiratory pressures in polymyositis and dermatomyositis. J Rheumatol. 1985 Feb;12(1):104–107. [PubMed] [Google Scholar]
  9. Sauty A., Rochat T., Schoch O. D., Hamacher J., Kurt A. M., Dayer J. M., Nicod L. P. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J. 1997 Dec;10(12):2907–2912. doi: 10.1183/09031936.97.10122907. [DOI] [PubMed] [Google Scholar]
  10. Steinberg A. D. Chlorambucil in the treatment of patients with immune-mediated rheumatic diseases. Arthritis Rheum. 1993 Mar;36(3):325–328. doi: 10.1002/art.1780360306. [DOI] [PubMed] [Google Scholar]
  11. al-Janadi M., Smith C. D., Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol. 1989 Dec;16(12):1592–1596. [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES